Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Dermatologic 1

Conditions

Precancerous Conditions 1Keratosis, Actinic 1

Interventions

3-ingenyl angelate 11Photochemotherapy 7Aminolevulinic Acid 7Imiquimod 6methyl 5-aminolevulinate 5Fluorouracil 5Gels 4Diclofenac 4Cryotherapy 3BF-200 ALA 3tirbanibulin 2Therapeutics 2Solutions 2green tea extract polyphenone E 1cetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotion 1Ointments 1LEO 43204 1Drugs, Generic 1Deoxyribonuclease (Pyrimidine Dimer) 1Cryosurgery 1Cosmetics 15-fluorouracil, salicylic acid drug combination 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Keratosis, Actinic × Deoxyribonuclease (Pyrimidine Dimer) × Clear all
NCT00002811 2013-11-06

T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum

National Cancer Institute (NCI)

Phase 3 Unknown
30 enrolled
DermatologicOther neoplasm

Precancerous Conditions, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡